Reuters logo
BRIEF-Galmed Pharmaceuticals Q3 loss per share $0.34
November 7, 2016 / 2:03 PM / a year ago

BRIEF-Galmed Pharmaceuticals Q3 loss per share $0.34

Nov 7 (Reuters) - Galmed Pharmaceuticals Ltd

* Galmed pharmaceuticals - CFO Josh Blacher has notified co of his wish to leave co to pursue other opportunities, effective January 31, 2017

* Galmed Pharmaceuticals says has accepted Blacher’s resignation and intends to appoint a new cfo in due course

* Galmed Pharmaceuticals says Yohai Stenzler, co’s director of finance, will act as interim CFO

* Galmed Pharmaceuticals reports third quarter 2016 financial results and provides business update

* Q3 loss per share $0.34

* Q3 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S

* Q3 revenue $200,000

* Q3 revenue view $0 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below